ATG overdose in a kidney-grafted patient. Clinical course and possible implications.
During antirejection treatment with antithymocyte globulin (ATG), a 48-year-old male kidney graft recipient was erroneously given 30 mg/kg ATG on day 5 of the treatment course. Clinically, the patient presented with abdominal pain, profuse diarrhea, and fever. Initially, the platelet count dropped to 94 x 10(3)/microliters and showed a further decrease to 65 x 10(3)/microliters 2 days thereafter. Plasmapheresis carried out about 12 h after the end of ATG infusion resulted in a decrease in serum levels of total rabbit immunoglobulin as well as the antibody fraction reactive with human T lymphocytes. Within 10 days after the discontinuation of ATG treatment, the relative and absolute number of the T-cell subpopulations, which had disappeared from the circulation at the time of antirejection therapy, returned to normal values. In addition, at this time both platelet and lymphocyte counts were again found to be in the normal range. Kidney function had recovered from the rejection crisis such that the patient could be discharged 26 days posttransplantation.
Zlabinger
G J
GJ
Institut für Immunologie der Universität, Wien, Austria.
Pohanka
E
E
Doleschel
W
W
Zielinski
C
C
Wolf
H
H
Kovarik
J
J
D000961:Antilymphocyte Serum / Q000008:administration & dosage / Q000009:adverse effects*; D003967:Diarrhea / Q000209:etiology; D005334:Fever / Q000209:etiology; D006801:Humans; D007049:Iatrogenic Disease / Q000097:blood / Q000209:etiology* / Q000628:therapy; D016030:Kidney Transplantation; D007970:Leukopenia / Q000209:etiology; D008297:Male; D008875:Middle Aged; D010146:Pain / Q000209:etiology; D010956:Plasmapheresis; D013601:T-Lymphocytes / Q000276:immunology*; D013921:Thrombocytopenia / Q000209:etiology
D000961:Antilymphocyte Serum